Al Basit Optical
✅ Low Risk
FEI: 3004909641 • Karachi • PAKISTAN
FEI Number
3004909641
Location
Karachi
Country
PAKISTANAddress
Metro Place Market, , Karachi, , Pakistan
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 2/18/2005 | 86LPLLENSES, SOFT CONTACT, DAILY WEAR | 341REGISTERED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Al Basit Optical's FDA import refusal history?
Al Basit Optical (FEI: 3004909641) has 1 FDA import refusal record(s) in our database, spanning from 2/18/2005 to 2/18/2005.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Al Basit Optical's FEI number is 3004909641.
What types of violations has Al Basit Optical received?
Al Basit Optical has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Al Basit Optical come from?
All FDA import refusal data for Al Basit Optical is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.